230 related articles for article (PubMed ID: 31357595)
1. Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation.
Cai BH; Chao CF; Huang HC; Lee HY; Kannagi R; Chen JY
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357595
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
[TBL] [Abstract][Full Text] [Related]
3. A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.
Cai BH; Chao CF; Lin HC; Huang HY; Kannagi R; Chen JY
J Biochem; 2016 Jun; 159(6):563-72. PubMed ID: 26823482
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
5. Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53.
Cai BH; Chen JY; Lu MH; Chang LT; Lin HC; Chang YM; Chao CF
Nucleic Acids Res; 2009 Apr; 37(6):1984-90. PubMed ID: 19208646
[TBL] [Abstract][Full Text] [Related]
6. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
Ethayathulla AS; Nguyen HT; Viadiu H
J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
[TBL] [Abstract][Full Text] [Related]
8. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data.
Sbisà E; Catalano D; Grillo G; Licciulli F; Turi A; Liuni S; Pesole G; De Grassi A; Caratozzolo MF; D'Erchia AM; Navarro B; Tullo A; Saccone C; Gisel A
BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S20. PubMed ID: 17430565
[TBL] [Abstract][Full Text] [Related]
9. A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63.
Cai BH; Chao CF; Lu MH; Lin HC; Chen JY
J Biochem; 2012 Jul; 152(1):99-110. PubMed ID: 22577164
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.
Menendez D; Inga A; Resnick MA
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1500-5. PubMed ID: 20080630
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the mechanism of p73 recognition of p53 response elements using the crystal structure of p73-DNA complexes and computational studies.
Koley T; Chowdhury SR; Kushwaha T; Kumar M; Inampudi KK; Kaur P; Singh TP; Viadiu H; Ethayathulla AS
Int J Biol Macromol; 2022 May; 206():40-50. PubMed ID: 35217090
[TBL] [Abstract][Full Text] [Related]
12. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
13. Structure and kinetic stability of the p63 tetramerization domain.
Natan E; Joerger AC
J Mol Biol; 2012 Jan; 415(3):503-13. PubMed ID: 22100306
[TBL] [Abstract][Full Text] [Related]
14. DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma.
Strubel A; Münick P; Hartmann O; Chaikuad A; Dreier B; Schaefer JV; Gebel J; Osterburg C; Tuppi M; Schäfer B; Buck V; Rosenfeldt M; Knapp S; Plückthun A; Diefenbacher ME; Dötsch V
Cell Death Dis; 2023 Oct; 14(10):674. PubMed ID: 37828008
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of DNA binding sites by mutant p53 proteins.
Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
[TBL] [Abstract][Full Text] [Related]
16. Early diversification and complex evolutionary history of the p53 tumor suppressor gene family.
Nedelcu AM; Tan C
Dev Genes Evol; 2007 Dec; 217(11-12):801-6. PubMed ID: 17924139
[TBL] [Abstract][Full Text] [Related]
17. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
[TBL] [Abstract][Full Text] [Related]
18. Role of the newer p53 family proteins in malignancy.
Irwin MS; Kaelin WG
Apoptosis; 2001; 6(1-2):17-29. PubMed ID: 11321038
[TBL] [Abstract][Full Text] [Related]
19. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
20. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements.
Raimondi I; Ciribilli Y; Monti P; Bisio A; Pollegioni L; Fronza G; Inga A; Campomenosi P
PLoS One; 2013; 8(7):e69152. PubMed ID: 23861960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
